This inventor holds 1 USPTO granted patent, plus 3 CIPO patents and 1 EPO patent. Top assignee: Nono Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: James Gurd: Innovating Treatments for Epilepsy
Introduction
James Gurd, an accomplished inventor based in Toronto, Canada, has made significant contributions to the field of medical technology. With a focus on neurological disorders, his work has the potential to improve the lives of those affected by epilepsy. He holds one patent that revolves around a novel approach to treatment.
Latest Patents
James Gurd's patent, titled "Treatment for Epilepsy," introduces methods for treating patients with this challenging condition. The invention details a regimen involving an agent that effectively inhibits the specific binding of PSD-95 to the NMDA receptor. This innovative approach aims to provide a new therapeutic avenue for managing epilepsy.
Career Highlights
Gurd is associated with Nono Inc., a company known for its pioneering efforts in medical advancements. His role there has allowed him to explore and develop his inventive ideas, particularly in the area of neurological treatment. His research is recognized for its potential impact on patient care and medication efficacy.
Collaborations
At Nono Inc., James collaborates with talented professionals such as Crystal Dykstra and Michael Tymianski. Together, they work towards innovative solutions that address pressing medical challenges, harnessing their collective expertise to drive advancements in therapeutics.
Conclusion
James Gurd is an inspiring figure in the realm of medical innovation, focusing on groundbreaking treatment methods for epilepsy. His patent represents not just a personal achievement, but also a hopeful step forward in the treatment of neurological disorders. With continued collaboration and research, Gurd and his team at Nono Inc. are poised to make lasting contributions to medical science.